Tests genetic testing to guide psychiatric medicine choices in Manitoba
Tests genetic testing to guide medicine choices in adults with mental illness.
Plain-language title generated from the registry record
Registry title: Pharmacogenomics-Supported Psychotropic Prescribing Trial
Key facts
- Where
- Winnipeg, CanadaSee the 2 sites
Where in Canada
- Shared Health FacilitiesWinnipeg, CanadaNot yet recruiting
- University of Manitoba College of PharmacyWinnipeg, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Manitoba
- Trial code
- NCT06929533
- Record updated
- 8 September 2025
- Original description
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.Read full original descriptionShow less
Pharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Inclusion: Aged 18 years or older; The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated; The treating clinician thinks PGx testing can benefit and refers the patient to the study.
Exclusion: History of liver or bone marrow (hematopoietic cell) transplantation; Unwillingness to donate saliva samples for genetic analysis; PGx testing results are already available; No personal health identification number (PHIN) is available.